Limb surgery requiring exsanguination and hemostasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age between 18 and 78 years; 2) Underwent limb surgery requiring exsanguination and hemostasis; 3) Anticipated surgical duration within 60 minutes; 4) Upper arm circumference between 24-40 cm or mid-thigh circumference between 28-60 cm; 5) Were willing to participate, comply with study requirements, follow-up arrangements, and sign informed consent.
Exclusion criteria
Exclusion criteria: 1) Female patients pregnant or lactating during screening; 2) Severe skin damage on limbs; 3) Known inadequate peripheral blood flow, edema, or deep venous thrombosis; 4) Patients with limb infections or malignancies; 5) Patients who experienced severe discomfort, such as cardiovascular risks or respiratory difficulties, from prior tourniquet use; 6) Inability to stabilize systolic blood pressure below 180 mmHg preoperatively; 7) Participation in other drug or device clinical trials within the last month of screening; 8) Other circumstances deemed unsuitable by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative blood loss; | — |
Secondary
| Measure | Time frame |
|---|---|
| Exsanguination and hemostasis effectiveness;Total blood loss;Hemoglobin content before and after surgery; | — |
Countries
China
Contacts
Department of Orthopedics, the Second Affiliated Hospital of Zhejiang University, School of Medicine